Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives $182.79 Average Target Price from Analysts
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) has earned an average rating of “Moderate Buy” from the fourteen brokerages that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average twelve-month price target among brokers […]
Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) has earned an average rating of “Moderate Buy” from the fourteen brokerages that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average twelve-month price target among brokers […]
